Nordea Investment Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-9,663
Closed -$256K – 972
2022
Q3
$256K Buy
9,663
+2,948
+44% +$103K ﹤0.01% 947
2022
Q2
$217K Sell
6,715
-410
-6% -$17.4K ﹤0.01% 952
2022
Q1
$520K Hold
7,125
– – ﹤0.01% 889
2021
Q4
$682K Hold
7,125
– – ﹤0.01% 871
2021
Q3
$903K Hold
7,125
– – ﹤0.01% 828
2021
Q2
$1.19M Sell
7,125
-3,829
-35% -$620K ﹤0.01% 763
2021
Q1
$1.97M Buy
10,954
+968
+10% +$225K ﹤0.01% 692
2020
Q4
$2M Buy
9,986
+6,374
+176% +$1.3M ﹤0.01% 689
2020
Q3
$788K Sell
3,612
-3,612
-50% -$765K ﹤0.01% 751
2020
Q2
$1.38M Buy
+7,224
New +$1.27M ﹤0.01% 758
2019
Q2
– Sell
-815
Closed -$45K – 1250
2019
Q1
$45K Buy
+815
New +$49.8K ﹤0.01% 1220

Other funds holding TDOC

Nordea Investment Management's TDOC Position: Q4 2022 in Review

Nordea Investment Management sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 9,663 shares — an estimated $256K sold.

Nordea Investment Management first reported a position in TDOC in Q1 2019 and held it in 11 quarters. The position peaked at $2M in Q4 2020. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Nordea Investment Management reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Nordea Investment Management sold 9,663 Teladoc Health shares in Q4 2022, an estimated $256K.
  • Nordea Investment Management first reported a position in Teladoc Health in Q1 2019 and held it in 11 quarters.
  • Nordea Investment Management's Teladoc Health position peaked at $2M in Q4 2020.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Nordea Investment Management's 13F filing for Q4 2022, filed 8 Feb 2023.